ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.
A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.
A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.
A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.
A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.
President Trump signed an order creating a task force led by VP J.D. Vance to combat fraud in federal health care and benefit programs.
Read More
Antiretroviral therapy reduces biological aging in HIV patients by nearly four years, showing recovery through the Proteomic Age Clock.
Read More
Novo Nordisk’s etavopivat reduced vaso-occlusive crises by 27% in Phase 3 trial for sickle cell disease; FDA approval expected in late 2026.
Read More
The AMA-backed Mental Health Parity Index tool reveals real-time insurance coverage and payment gaps for mental health across 43 states and 70% of counties.
Read More
A major U.S. hospital chain faced challenges covering GLP-1 weight loss drugs like Ozempic in employee health plans amid rising costs.
Read More
A study links late-stage syphilis in U.S. adults to higher risks of stroke, heart attack, and nearly sixfold increased mortality rates.
Read More
Anthropic quietly released a specification that lets any AI tool access any data source through a single standard interface. Within months, the entire ecosystem adopted it. The biggest use case — pers
Read More
Researchers engineered myeloid cells to deliver interleukin-12 to tumors, activating immune cells and reducing lung metastases in mice.
Read More
JAMA published an analysis on the 2025-2026 COVID vaccines’ effectiveness against new Omicron subvariants LP.8.1 and JN.1 in the U.S.
Read More
Colorectal cancer screening among U.S. adults aged 45-49 rose to 34.5% in 2022 following updated screening guidelines.
Read More
